Medical Developments International Limited (ASX:MVP)

Market Cap	65.34M
Revenue (ttm)	38.05M
Net Income (ttm)	-29.74M
Shares Out	112.66M
EPS (ttm)	-0.31
PE Ratio	n/a
Forward PE	42.03
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,684
Average Volume	104,214
Open	0.5900
Previous Close	0.5750
Day's Range	0.5700 - 0.6050
52-Week Range	0.3850 - 0.9400
Beta	1.50
RSI	50.73
Earnings Date	Aug 26, 2025

About ASX:MVP

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, po...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 68
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: MVP

Financial Performance

In 2024, ASX:MVP's revenue was 33.15 million, an increase of 2.51% compared to the previous year's 32.34 million. Losses were -40.99 million, 630.8% more than in 2023.